Recent Finacing
Recent Raise
Iktos builds AI drug-discovery platforms Makya and Spaya that generate optimized small-molecule designs in silico, offered as SaaS and professional services, expanding into automated end-to-end discovery and biologics.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Iktos.
